Robbins Umeda LLP Announces an Investigation of the Acquisition of ATS Medical, Inc. by Medtronic, Inc.
29 Abril 2010 - 7:12PM
Business Wire
Robbins Umeda LLP has commenced an investigation into possible
breaches of fiduciary duty and other violations of state law by
members of the Board of Directors of ATS Medical, Inc. ("ATS")
(NASDAQ: ATSI) in connection with their actions in causing ATS to
enter into a definitive agreement with Medtronic, Inc.
("Medtronic") (NYSE: MDT). If the transaction is completed, ATS
shareholders will receive $4.00 in cash for each share of ATS they
own.
Robbins Umeda LLP's investigation concerns whether ATS's Board
of Directors undertook a fair process to obtain fair consideration
for all shareholders of ATS.
If you are a shareholder of ATS and would like more information
about your rights as a shareholder, please contact attorney Lauren
Levi at 800-350-6003 or by e-mail at llevi@robbinsumeda.com.
Robbins Umeda LLP is a California-based law firm with
significant experience representing investors in merger-related
shareholder class actions, shareholder derivative actions, and
securities fraud class actions. For more information about the
firm, please go to http://www.robbinsumeda.com.
Advertisement
Ats Medical (MM) (NASDAQ:ATSI)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Ats Medical (MM) (NASDAQ:ATSI)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Ats Medical (MM) da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Robbins Umeda LLP